Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Hyperparathyroidism, Primary × Tablets × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 3 Vomiting 1 Prostatic Neoplasms 1 Parathyroid Neoplasms 1 Neoplasms 1 Leukemia, Myeloid, Chronic-Phase 1 Leukemia, Myeloid, Acute 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Leukemia, Hairy Cell 1 Leukemia, B-Cell 1 Hyperparathyroidism, Primary 1 Hot Flashes 1 Erectile Dysfunction 1 Diabetes Mellitus 1 Carcinoma, Renal Cell 1

Interventions

Cinacalcet 2 evocalcet 1 Tablets 1 Sodium Chloride 1 Denosumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03027557 2021-05-25

DENOCINA

Aalborg University Hospital

Phase 3 Completed

46 enrolled 49 charts

Parathyroid Neoplasms, Hyperparathyroidism, Primary

Data powered by HemOnc (CC BY 4.0) Colophon ⚡